Phibro Animal Health (PAHC) EV to EBITDA (2014 - 2026)

Phibro Animal Health has reported EV to EBITDA for 13 years, with the latest figure at 24.73 in Q2 2026.

• On a quarterly basis, EV to EBITDA fell 12.92% year-over-year to 24.73 in Q2 2026; TTM through Jun 2026 was 6.13, a 29.32% decrease from a year earlier, with the FY2026 full-year figure at 6.13, down 29.32% from the prior year.
• EV to EBITDA was 24.73 for Q2 2026 at Phibro Animal Health, down from 48.49 in the prior quarter.
• The five-year high for EV to EBITDA was 48.49 in Q1 2026, with the low at 586.89 in Q3 2023.
• Average EV to EBITDA over 5 years is 3.93, with a median of 29.31 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: EV to EBITDA sank 1876.7% in 2023, then soared 107.92% in 2024.
• Over 5 years, EV to EBITDA stood at 29.33 in 2022, then retreated by 18.24% to 23.98 in 2023, then gained by 27.95% to 30.69 in 2024, then dropped by 6.76% to 28.61 in 2025, then fell by 13.55% to 24.73 in 2026.
• The last three EV to EBITDA figures came in at 24.73 (Q2 2026), 48.49 (Q1 2026), and 28.61 (Q4 2025), per Business Quant data.